175 related articles for article (PubMed ID: 11238531)
1. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults.
Gupta S; Patel A; Folstad A; Fenton C; Dinauer CA; Tuttle RM; Conran R; Francis GL
J Clin Endocrinol Metab; 2001 Mar; 86(3):1346-54. PubMed ID: 11238531
[TBL] [Abstract][Full Text] [Related]
2. Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents.
Shah R; Banks K; Patel A; Dogra S; Terrell R; Powers PA; Fenton C; Dinauer CA; Tuttle RM; Francis GL
J Clin Endocrinol Metab; 2002 Sep; 87(9):4391-7. PubMed ID: 12213904
[TBL] [Abstract][Full Text] [Related]
3. Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes.
Modi J; Patel A; Terrell R; Tuttle RM; Francis GL
J Clin Endocrinol Metab; 2003 Sep; 88(9):4418-25. PubMed ID: 12970319
[TBL] [Abstract][Full Text] [Related]
4. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
5. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic infiltration in pediatric thyroid carcinomas.
Van Savell H; Hughes SM; Bower C; Parham DM
Pediatr Dev Pathol; 2004; 7(5):487-92. PubMed ID: 15547772
[TBL] [Abstract][Full Text] [Related]
7. Thyroid cancers express CD-40 and CD-40 ligand: cancers that express CD-40 ligand may have a greater risk of recurrence in young patients.
Costello A; Rey-Hipolito C; Patel A; Oakley K; Vasco V; Calabria C; Tuttle RM; Francis GL
Thyroid; 2005 Feb; 15(2):105-13. PubMed ID: 15753667
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
9. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma.
Lindhorst E; Schumm-Draeger PM; Bojunga J; Usadel KH; Herrmann G
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):27-31. PubMed ID: 11835122
[TBL] [Abstract][Full Text] [Related]
10. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
[TBL] [Abstract][Full Text] [Related]
11. Differentiated thyroid carcinomas from children and adolescents express IGF-I and the IGF-I receptor (IGF-I-R). Cancers with the most intense IGF-I-R expression may be more aggressive.
Gydee H; O'Neill JT; Patel A; Bauer AJ; Tuttle RM; Francis GL
Pediatr Res; 2004 Apr; 55(4):709-15. PubMed ID: 14973173
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
13. Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer.
Souza SL; Montalli Da Assumpção LV; Ward LS
Thyroid; 2003 May; 13(5):491-5. PubMed ID: 12855017
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between the pathological characteristics and the prognosis of thyroid carcinoma].
Liu FS
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):381-4. PubMed ID: 8174487
[TBL] [Abstract][Full Text] [Related]
15. [Surgical therapy of differentiated thyroid gland carcinoma].
Walgenbach S; Sternheim E; Bittinger F; Junginger T
Zentralbl Chir; 1997; 122(4):252-8. PubMed ID: 9221635
[TBL] [Abstract][Full Text] [Related]
16. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
French JD; Weber ZJ; Fretwell DL; Said S; Klopper JP; Haugen BR
J Clin Endocrinol Metab; 2010 May; 95(5):2325-33. PubMed ID: 20207826
[TBL] [Abstract][Full Text] [Related]
18. [Thyroid cancers].
Mogoş V; Zbranca E; Strat V; Diaconescu MR; Chifan M; Florea N; Costăchescu G; Găleşanu MR; Rusu V; Georgescu G
Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):72-81. PubMed ID: 9524659
[TBL] [Abstract][Full Text] [Related]
19. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
20. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents.
Patel A; Jhiang S; Dogra S; Terrell R; Powers PA; Fenton C; Dinauer CA; Tuttle RM; Francis GL
Pediatr Res; 2002 Nov; 52(5):737-44. PubMed ID: 12409522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]